Meta-benzamidine derivatives as serine protease inhibitors

Details Meta-benzamidine derivatives as serine protease inhibitors Meta-benzamidine derivatives as serine protease inhibitors

2007-05-22

2007-05-22

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S357000, C514S538000, C514S563000, C514S617000, C544S353000, C544S365000, C546S194000, C546S280700, C546S281100, C560S035000, C560S251000, C562S440000, C564S157000, C564S161000, C564S246000

Reexamination Certificate

active

10752568

ABSTRACT:
Compounds of formula Iin which R1, R2, R3, each X, L, Y, Cy, Lp, D and n have the meanings as set out in the specification, and corresponding compounds in which the unsubstituted or substituted amidine group is replaced with an unsubstituted or substituted aminomethyl group, are useful as serine protease inhibitors.

REFERENCES:
patent: 6080767 (2000-06-01), Klein et al.
patent: 6498165 (2002-12-01), Armstrong et al.
patent: 6545055 (2003-04-01), Zhu et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6916957 (2005-07-01), Lively et al.
patent: 0483667 (1992-05-01), None
patent: 0540051 (1993-05-01), None
patent: 0588655 (1994-03-01), None
patent: 0672658 (1995-09-01), None
patent: WO 92/08709 (1992-05-01), None
patent: WO 94/29336 (1994-12-01), None
patent: WO 95/13274 (1995-05-01), None
patent: WO 97/24118 (1997-07-01), None
patent: WO 97/24135 (1997-07-01), None
patent: WO 97/36859 (1997-10-01), None
patent: WO 00/71507 (2000-11-01), None
patent: WO 00/71508 (2000-11-01), None
patent: WO-00/71508 (2000-11-01), None
patent: WO 00/79453 (2000-11-01), None
Ferroni et al. “Ethylesters of N-amidinobenzoyl amino acids . . . ” CA 108:48724 (1987).
Exhibit I, structure delineation for priority WO99/11658.
Liebeschuetz et al. Preparation of meta-benzamidine . . . CA 130:237884 (1999).
R. Ferroni et al; 1 Farmaco Ed Sci (1987)42(10)pp. 709-715. (Chemical Abstracts, vol. 108 No.7 Dec. 23, 1985 Columbus, Ohio, US; Abstract No. 48724q. XP00208333.
R. Ferroni et al; I1 Farmaco Ed Sci (1985)40(10)pp. 717-729. (Chemical Abstracts, vol. 103, No. 25, Dec. 23, 1985 Columbus, Ohio, US; Abstract No. 209699z, XP002083330).
J. Sturzebecher et al; Thrombosis Research (1976)9(6)pp. 637-646.
Alig et al., “Low molecular weight, nonpeptide fibrinogen receptor antagonists” CA 118: 7363.
B. R. Baker et al; Journal of Medicinal Chemistry, vol. 12, No. 3, 1969, p. 408-414, Washington US. (Chemical Abstracts, vol. 71, No. 7 Aug. 18, 1969, Columbus, Ohio, US; Abstract No. 28982m,XP002083332).
H. Vieweg et al; Pharmazie, vol. 38, No. 12, 1983, p. 818-820 Berlin DE. (Chemical Abstracts, vol. 101, No. 1, Jul. 2, 1984, Columbus, Ohio, US; Abstract No. 6764c, XP002083333).

Affiliated with

Also associated with

Rating

Meta-benzamidine derivatives as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Meta-benzamidine derivatives as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meta-benzamidine derivatives as serine protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3802924